Legal status · United States
Is Oveporexton legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Oveporexton is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 6 completed human trials are cited on its profile.
- People given it
- 441
- Found nothing
- 0
Legal category
FDA-approved, prescription only
Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults. Listed as Prescription in the FDA drug database (Drugs@FDA). Its controlled drug schedule is still pending.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
Oveporexton in the United States at a glance
| Legal category | FDA-approved, prescription only |
|---|---|
| Note | Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults. Listed as Prescription in the FDA drug database (Drugs@FDA). Its controlled drug schedule is still pending. |
| FDA approval status | FDA approved 5 August 2026 (Orzeyful, NDA 220860) for narcolepsy type 1 in adults. It had orphan status, which is for drugs that treat rare diseases, and a priority (faster) FDA review. When the label was written, the DEA had not yet decided which controlled drug schedule it falls under. |
| Studies in people | 6 of 9 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the Oveporexton profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
FDA has approved Oveporexton for at least one use named on its label. So a proper pharmacy-grade product exists in the United States, and pharmacies hand it out on prescription.
- 02
Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.
- 03
Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.
What Oveporexton is
A pill for narcolepsy type 1 that works on the brain's orexin wake system. It is not a peptide. The FDA approved it for adults on 5 August 2026. In two 12 week studies of 273 people, it kept people awake 14 to 20 minutes longer on a stay-awake test, while the dummy pill groups barely changed. Most people on it had trouble sleeping at night and needed to pee more often.
Oveporexton is a small molecule, not a peptide. 51 daltons.
How it works: In narcolepsy type 1, the brain cells that make orexin-A and orexin-B die off. So both orexin peptides run short, but the receptors they act on are still there.
Approval history: FDA approved 5 August 2026 (Orzeyful, NDA 220860) for narcolepsy type 1 in adults. It had orphan status, which is for drugs that treat rare diseases, and a priority (faster) FDA review. When the label was written, the DEA had not yet decided which controlled drug schedule it falls under.
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Oveporexton on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
Oveporexton in sport and the military
Whether Oveporexton is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Oveporexton by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
Oveporexton in other countries
Frequently asked questions
Is Oveporexton legal in the United States?
Yes. Oveporexton is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 6 completed human trials are cited on its profile. Note: Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults. Listed as Prescription in the FDA drug database (Drugs@FDA). Its controlled drug schedule is still pending.
Can I buy Oveporexton in the United States?
Only with a prescription. In the United States, Oveporexton has the legal category "FDA-approved, prescription only". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults. Listed as Prescription in the FDA drug database (Drugs@FDA). Its controlled drug schedule is still pending.
Is Oveporexton FDA approved?
Yes. FDA status: FDA approved 5 August 2026 (Orzeyful, NDA 220860) for narcolepsy type 1 in adults. It had orphan status, which is for drugs that treat rare diseases, and a priority (faster) FDA review. When the label was written, the DEA had not yet decided which controlled drug schedule it falls under.. Current US legal category: "FDA-approved, prescription only". On the evidence, 6 completed human trials are cited on its profile.
Related compounds in the United States
Full research profile
How Oveporexton works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
Oveporexton profileThis page is general information about the legal status of Oveporexton in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.